New Drug Therapy To Combat Graft-vs.-Host Disease In Stem-Cell Patients Shows Significant Reduction In Deaths

Wed, 24 Jan 2007 02:00 PM EST

... Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. [click link for full article] ...